Correlating telomerase activity levels with human neuroblastoma outcomes

Eiso Hiyama, Keiko Hiyama, Takashi Yokoyama, Yuichiro Matsuura, Mieczyslaw A. Piatyszek, Jerry W. Shay

Research output: Contribution to journalArticle

602 Scopus citations

Abstract

Telomerase activity was analysed in 100 neuroblastoma cases. Although telomerase activity was not detected in normal adrenal tissues or benign ganglioneuromas, almost all neuroblastomas (94%) did express it, suggesting an important role for telomerase in neuroblastoma development. Neuroblastomas with high telomerase activity had other genetic changes (for example, N-myc amplification) and an unfavourable prognosis, whereas tumours with low telomerase activity were devoid of such genetic alterations and were associated with a favourable prognosis. Three neuroblastomas lacking telomerase activity regressed (stage IVS). Thus telomerase expression may be required as a critical step in the multigenetic process of tumorigenesis, and two different pathways may exist for the development of neuroblastoma.

Original languageEnglish (US)
Pages (from-to)255
Number of pages1
JournalNature Medicine
Volume1
Issue number3
DOIs
Publication statusPublished - 1995

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., & Shay, J. W. (1995). Correlating telomerase activity levels with human neuroblastoma outcomes. Nature Medicine, 1(3), 255. https://doi.org/10.1038/nm0395-249